The tumor-killing ability of HIF-1 in CD8+ T cells is controversial because HIF-1 overexpression in CD8+ T cells increases the level of infiltration and tumor-killing ability of CD8+ T cells (101). The gene discussed is CD8A; the disease is neoplasm.